Invention Grant
- Patent Title: Glycopegylated interferon α
- Patent Title (中): 糖基化干扰素α
-
Application No.: US11659942Application Date: 2005-09-12
-
Publication No.: US08268967B2Publication Date: 2012-09-18
- Inventor: Shawn DeFrees , David A. Zopf , Henrik Clausen , Ruye Xing
- Applicant: Shawn DeFrees , David A. Zopf , Henrik Clausen , Ruye Xing
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2005/032565 WO 20050912
- International Announcement: WO2006/031811 WO 20060323
- Main IPC: C07K14/56
- IPC: C07K14/56 ; A61K38/21

Abstract:
The present invention provides IFN-α conjugates including IFN-α peptides and modifying groups such as PEG moieties. The IFN-α peptide and modifying group are linked via an intact glycosyl linking group interposed between and covalently attached to the IFN-α peptide and the modifying group. The IFN-α conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar onto an amino acid or a glycosyl residue on the IFN-α peptide. Also provided are methods for preparing the IFN-α conjugates, methods for treating various disease conditions with the IFN-α conjugates, and pharmaceutical formulations including the IFN-α conjugates.
Public/Granted literature
- US20090028822A1 Glycopegylated Interferon Alpha Public/Granted day:2009-01-29
Information query